Company Overview

Company name: G&G Laboratories
Description: Owner and operator of a research and development company intended to help in non-addictive pain management therapies. The company applies a pharmaceutical technology to develop cannabis topicals which targets chronic pain and sports injuries, enabling customers to purchase their products which deliver active ingredients up to 25 millimeters below the skin in a non-toxic, non-traumatic way.
Year founded: 2017
Parent company:
Industry: Consumer Products and Services (B2C) | Group: Consumer Non-Durables | Code:
Website: www.gnglaboratories.co
Employees:
City:
State: California
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 0.81
Business status: Startup
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised $813,309 of angel funding in the form of SAFE note via Republic on January 1, 2018, putting the company’s pre-money valuation at $15.187 million.
Number of active investors:
Profile last updated: 08-Nov-2018
Last known valuation: 16.00
Last known valuation date: 01-Jan-2018